Physician profile
Jason Fishbein
NPI 1972602555
$3,827.67
in general payments reported to CMS, 2019-2025
43 companies · $1,315 in 2025
The $1,315 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $359 · 2021: $385 · 2022: $476 · 2023: $188 · 2024: $798 · 2025: $1,315.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,301.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $392.60 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $316.27 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Merck Sharp & Dohme LLC | $263.16 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $261.60 | 2019-2025 | Jardiance, Synjardy |
| Novartis Pharmaceuticals Corporation | $248.41 | 2022-2025 | |
| Medtronic, INC. | $211.25 | 2024-2025 | Minimed 780g |
| Amarin Pharma, INC. | $185.75 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $143.18 | 2024-2025 | Recorlev |
| Pfizer INC. | $142.69 | 2019-2024 | |
| Amgen INC. | $128.60 | 2021-2025 | Evenity, Prolia, Tepezza |
| Eisai INC. | $125.26 | 2025 | |
| Abbott Laboratories | $114.92 | 2019-2024 | Mitraclip, Navitor |
| Amneal Pharmaceuticals LLC | $113.41 | 2024-2025 | Unithroid |
| Exact Sciences Corporation | $99.02 | 2023-2025 | Cologuard Collection Kit |
| Tandem Diabetes Care, INC. | $92.75 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Fishbein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.